Skip to the main content.
Facebook Instagram Linkedin X YouTube Medium

megamenu-services

 

Turn Vision into Velocity with the Innovation CRO

Traditional CROs fragment device development with costly hand-offs and learning curves. Veranex unites the essential disciplines for medical device & diagnostic development under one roof from sketch to evidence-generation to market launch.

All connected. All aligned. All accelerating your path to market—delivering breakthrough devices and diagnostics that improve patient lives sooner.

Explore our Services

megamenu-solutions-expertise

 

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Solutions
Expertise

megamenu-company-2

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Explore our Company

VRX EUROPCR Logos

Veranex Experts at EuroPCR & Innovators Day

Align your clinical, regulatory, and commercialization strategy early and accelerate development.

May 18-22, 2026 | Paris, France

Euro PCR Booth M54
Innovators Day Booth H5

Book a Meeting
Tour Request

Why Teams Meet Veranex at EuroPCR

Move from innovation to approval with fewer delays, stronger submissions, and a clearer path to market.

Veranex provides coordinated strategy across clinical, regulatory, quality, and commercialization to reduce delays, misalignments, navigate risks. Our approach is grounded in real-world cardiovascular programs and evolving global regulatory expectations.

  • 700+ experts across clinical, regulatory, quality, and commercialization

  • Deep experience across interventional, structural heart, and vascular technologies

  • Proven support from early feasibility through global market access

  • Integrated model aligning clinical evidence with regulatory and commercial success

Talk with Our Team
BU Icons Flywheel_White
EUROPCR Section 2

Exclusive Sponsor of PCR Innovation Day

18 May 2026 | Paris, France

If you're making decisions that will define your development timeline, this pre-conference event focused on emerging cardiovascular technologies is the right moment to align your strategy.

Connect with us at Innovators Day, to discuss:

  • First-in-human readiness and early feasibility strategy

  • Clinical evidence planning under MDR and FDA pathways

  • Regulatory positioning across EU and US markets

  • Key inflection points for funding, trials, and commercialization

Book a Meeting

See how strategy translates into execution

Located in Paris, Veranex’s PCS preclinical facility supports cardiovascular device development through translational research, procedural simulation, and preclinical testing.

This is where early concepts become clinically and regulatorily viable.

During your visit, you’ll see how our teams integrate:

  • Preclinical and translational research
  • Clinical study design and execution
  • Regulatory and quality strategy
  • Commercialization planning
Schedule a Tour

EuroPCR is where critical decisions are made.

The teams that move fastest are the ones that align strategy early.

If you’re evaluating your next clinical, regulatory, or commercialization step, now is the time to have that conversation.

Book a Meeting